Ipca Laboratories Share Price

Ipca Laboratories (INR)1614.35-35.5   (-2.2%)

Exchange ScripsBSE524494NSEIPCALABISININE571A01038

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Ipca Laboratories Performance

Market performance
Open price1646
High1667.15
Volumes644123
Prev Close1614.35
Low1604.6
Closing date2024-10-21
Historical performance
1 Year High1708.65
3 Year High1708.65
5 Year High1708.65
1 Year Low958.05
3 Year Low669.80
5 Year Low460.25

Ipca Laboratories Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
41857
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
74.83
Dividend Yield
Dividend Yield
0.25 %

Ipca Laboratories Investment Returns

1 Year
72.5%
3 Years
42%
5 Years
241%
10 Years
371.4%

Ipca Laboratories Technicals

IndicatorsValueSignal
5-DMA1654.08Bearish
10-DMA1634.76Bearish
20-DMA1558.9Bullish
50-DMA1468.08Bullish
100-DMA1336.73Bullish
200-DMA1278.2Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters1616161616
Foreign Investors---------------
Domestic Investors1616161616
Public Investors8295984737811498279395914
Government---------------

Ipca Laboratories Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income1844151812171292
Operating Profit14484105501379316104
Interest1408482112123
Depreciation3572261623242092
Profit Before Tax842774531135713890
Consolidated Net Profit54734713884111400
Adjusted EPS22193545

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital254254254254
Total Reserves63052581665439546763
Minority Interest13948733769145
Total Non-Current Liabilities10144901761391897
Total Liabilities110970862297621560664
Capital Work in Progress3236122229391837
Total Assets110970862297621560664

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities94478058856110901
Cash Flow from Investing Activities-12918-7250-8550-5207
Cash Flow from Financing Activitie-552550724268-3058
Net Cash Inflow / Outflow-8997588042782636
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 74.83.
  • 3Y Stock Price CAGR of the stock is 12.3.
  • The stock has a beta of 0.4.
  • In the last financial year, the company had an EBITDA of ₹14484 Million.
  • The company generated revenue of ₹76624 Million in the previous financial year.

Ipca Laboratories

1614.35-35.5   (-2.2%)

Investment Amount: ₹ 99880
Current Value: ₹ 161435
Performence: 61.6%
P/L: ₹ 61555
Top Gainers
SymbolChange%
GFLLIMITED119.34(20%)
DIFFNKG408.3(20%)
SILINV877.1(20%)
PILANIINVS7536.05(20%)
TAINWALCHM280.75(20%)
Top Losers
SymbolChange%
PNCINFRA366.8(-20%)
INDIAMART2508.6(-17%)
RBLBANK176.14(-14%)
WABAG1710(-9%)
JMFINANCIL147.05(-7%)
MITCON107.19(-7%)
TATACONSUM1017.05(-7%)
AETHER862.6(-7%)
Similar stocks

Strides Pharma Scien

27.4

1638.55

September 21 - October 21

RPG Life Sciences

22.3

2749.85

September 21 - October 21

Jagsonpal Pharma

18.8

487.3

September 21 - October 21

Unichem Lab

17.3

757.95

September 21 - October 21

Windlas Biotech

14

1002.95

September 21 - October 21

Medicamen Biotech

10.9

513.3

September 21 - October 21

Gufic Biosciences

10.9

450.15

September 21 - October 21

Solara Active Pharma

9.7

822.35

September 21 - October 21

Announcing Stock of the Month!

Stock of the Month
Stock of the Month